Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial
Additionally, participants completed a three-day food record using the 2024 version of the Automated Self-Administered Dietary Assessment Tool, which was used to calculate each individual's average intake
The authors note that semaglutide had a holistic therapeutic approach to both liver disease and associated cardiometabolic illnesses. These results lend further credence that semaglutide is the Swiss army knife of medicine we have been looking for, to treat obesity, cardiovascular disease, type 2 diabetes, and now MASH, Beverly Tchang, MD, an endocrinologist and assistant professor of clinical medicine at Weill Cornell Medicine, not affiliated with the trial, told Healthline.
You and your healthcare provider can make a good plan together for your weight management
Special considerations for different GLP-1 medications While electrolyte principles apply across all GLP-1 medications, there are some differences worth noting between specific medications